Hospitals have courageously taken on the opioid industry in order to protect the healthcare of all potential patients.
Taylor Martino, P.C.’s team of trial lawyers focuses exclusively on representing the interests of injured people and businesses. Our attorneys have significant experience representing hospitals and other healthcare entities who have incurred financial loss. The firm represented hospitals and healthcare providers in the BP Oil Spill, recovering significant damages on their behalf. Taylor Martino has been retained by a group of hospitals and health care providers regarding their losses due to the opioid crisis and on November 30, 2017 filed the first Nationwide Class Action Lawsuit on behalf of all privately owned Hospitals to help them recover the enormous damages suffered during this healthcare calamity.
Hospitals were left out of the case against Big Tobacco, which weakened the ability of each indvidual facility to provide the highest available care to the citizens of its surrounding community. “The healthcare of American citizens cannot be ignored again.”
If your hospital or healthcare provider has suffered financial loss as a result of the opioid crisis, our experienced class action legal team and forensic CPA’s would like to speak with you. Please contact Taylor Martino at (800) 256-7728. Click here to review our Press Release.
What is an Opioid
Opioids are drugs formulated to replicate the pain reducing properties of opium. They include both legal painkillers like morphine, oxycodone, or hydrocodone prescribed by doctors for acute or chronic pain, as well as illegal drugs like heroin or illicitly made fentanyl. The word “opioid” is derived from the word opium. In the last decade, opioids have become the center of an American crisis. The amount of prescriptions being written for opioids has increased from 112 million written in 1992 to 282 million written in 2012, and those numbers are steadily rising.
The Opioid Effect and Cost
Approximately 2 million Americans are currently addicted to opioids, with the most common being hydrocodone (Vicodin, Lorcet & Lortab), Oxycodone (OxyContin, Percodan & Roxicet), methadone, fentanyl and morphine. More than 33,000 Americans die each year from opioid related drug overdose and it is the leading cause of death for people under 50 years old. The opioid Industry grosses over $13 billion in profit each year and the estimated annual cost of dealing with opioid abuse related problems is currently $78.4 billion dollars.
What Damages Can Be Recovered for Healthcare Providers for the treatment of patients with opioid addiction
- Unreimbursed charges for treatment of patients with opioid-related conditions
- Internal increase of costs/expenses dealing with pill seekers and treatment
Taylor Martino, P.C. retained a leading national forensic accounting firm to determine hospital losses due to the BP Oil Spill. The forensic accounting firm has been retained by Taylor Martino to assist in determining the losses incurred by the hospitals and other Healthcare providers due to the Opioid Crisis. Taylor Martino is also creating unique software from a leading healthcare software company which will assist hospitals in determining their total damages.
Litigating This Crisis
The purpose of the opioid litigation is to shift the cost of the opioid crisis from the healthcare industry to those responsible for the crisis, the wholesale drug distributors and drug manufacturers.
Therefore, we have filed a lawsuit against the country’s three largest wholesale drug distributors:
- Cardinal Health
and against the manufacturers of opioids:
- Purdue Pharma
- and others
The claims against the manufacturers are based on misrepresentations in the marketing and advertising of opioids. We believe manufacturers and distributors of opioid medications should bear the economic burden of opioid addiction – not the health care industry.
After a lawsuit is filed we expect that the case will eventually be transferred to a Federal Court for consideration of all opioid lawsuits nationwide. This is called Multi District Litigation (MDL). Taylor Martino has considerable experience litigating in MDLs across the county including representing Hospital in the BP MDL litigation in New Orleans, LA.
Frequently Asked Questions
Why should our hospital or healthcare provider get involved?
The opioid epidemic is devastating families and communities throughout America. At the same time, health care providers are struggling to foot the bill for the crisis. Your hospital or healthcare provider should get involved to be reimbursed for this cost. Many cities, counties and states are filing lawsuits and your hospital should be at the table.
How will Taylor Martino be paid?
Taylor Martino will receive a percentage of any money recovered in the lawsuit. If nothing is recovered, then Taylor Martino gets nothing. If there is a recovery, then Taylor Martino will get a percentage.
How much will it cost the Hospital or Healthcare Provider?
The attorneys at Taylor Martino will pay all expenses to litigate the case. The hospital or healthcare provider has to pay nothing in the litigation, but will be required to dedicate time and resources to determine damages.
Why can’t our attorneys handle this?
The Hospital or Healthcare Provider does have attorneys, but the prosecution of these types of cases may involve the investment of millions of dollars of expenses for expert analysis and scientific and medical data that the hospital or healthcare provider does not have. The hospital or healthcare provider will not be obligated to pay expenses under this arrangement.
In February, the Senate approved the nomination of Robert Califf, MD, to head the FDA, thwarting an effort by a group of senators to block his nomination over Califf’s ties to the pharmaceutical industry. MedPageToday article I am very concerned about the leadership of the FDA and the FDA’s safety standards for new drugs and…
On May 15, 2015 the FDA announced it is investigating an association between Farxiga, Jardiance, and Invokana with diabetic ketoacidosis (DKA), ketoacidosis, or ketosis. See: “FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood”. About a month later, Health Canada…